Kidney Donation Linked to Higher Risk of Later Pregnancy Complications

Living kidney donation offers incredible, life-saving benefits to patients experiencing organ failure, but evaluating the procedure requires careful consideration of both recipient outcomes and the long-term health of the donor. According to recent research presented at the American Society of Nephrology Kidney Week annual meeting and simultaneously published in JAMA, women who donate a kidney may face a moderately higher risk of gestational hypertensive disorders in subsequent pregnancies.

Understanding the Canadian Matched Cohort Study

The observational study, led by Dr. Amit X. Garg of the London Health Sciences Centre in Ontario and his colleagues, utilized administrative healthcare data spanning three Canadian provinces. Researchers tracked singleton pregnancies of at least 20 weeks gestation to evaluate maternal and neonatal outcomes among previous kidney donors compared to a matched control group of nondonors.

Among the participants, 11.9 percent of kidney donors experienced the study primary composite outcome, which involved hospitalization with a diagnosis of gestational hypertension, preeclampsia, or eclampsia. In comparison, 8.3 percent of matched nondonors experienced these same complications. This calculation yielded a risk ratio of 1.51, indicating a statistically significant association between prior kidney donation and later gestational hypertensive issues.

Furthermore, the investigation revealed that kidney donation prior to pregnancy was associated with higher rates of small-for-gestational-age births, occurring in 13.8 percent of donor pregnancies compared to 7.9 percent of nondonor pregnancies. However, study authors noted that this specific metric was one of several secondary outcomes examined and will require confirmation through subsequent research.

Most Post-Donation Pregnancies Proceed Safely

Despite the elevated statistical risks, experts emphasize that the vast majority of pregnancies following kidney donation still progress without major medical complications. Garg pointed out that gestational hypertensive disorders were typically recorded close to the end of the term, with fewer than two percent of pregnancies in either group experiencing the outcome before 34 weeks.

• Most post-donation pregnancies proceed without major issues.
• Hypertensive disorders were generally first recorded close to term.
• Fewer than two percent of cases were recorded before 34 weeks.

Because approximately 65 percent of living kidney donors are female, and roughly 75 percent fall within childbearing age at the time of their procedure, understanding these patterns is vital for clinical counseling. Garg stated that donor candidates who anticipate becoming pregnant should receive proper education regarding the modestly higher chance of developing gestational hypertension or preeclampsia. He added that a desire for future pregnancy should not automatically disqualify someone from becoming a living donor, provided they receive appropriate prenatal care that closely monitors blood pressure and other indicators of hypertensive disorders.

Biological Plausibility and Study Limitations

The observed association between kidney donation and gestational complications aligns with established biological mechanisms. Pregnancy places substantial demands on the maternal body, requiring significant increases in renal blood flow and glomerular filtration rates. Animal experimental models have previously demonstrated that unilaterally nephrectomized subjects exhibit impaired renal adaptation to pregnancy, potentially causing abnormal placental development and placental hypoperfusion, which is a shared pathway in both gestational hypertension and impaired fetal growth.

The study also highlighted subgroup variations. The calculated risk ratio for the primary outcome was larger among women aged 35 or older at delivery, affecting 14.3 percent of donors versus 7.6 percent of nondonors, compared to a smaller difference among younger participants.

The researchers acknowledged several inherent limitations within their analysis. Potential residual genetic confounding may exist because many living donors are blood relatives of their recipients and might share underlying genetic susceptibilities to renal dysfunction. Additionally, the administrative datasets lacked specific metrics regarding maternal body mass index, direct blood pressure measurements, and specific medication usage during pregnancy.